FHL1 and neoplasm: In the training cohort (n = 105), our results showed that low FHL1 mRNA levels were significantly associated with poorer tumor differentiation (p = 0.020) (Table 1) and worse OS (p = 0.018) or DFS (p = 0.038) (Figure 1G and 1H).